Planned Parenthood Of The Heartland Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1109 S. Summer Street, Creston, IA 50801 Phone: 866-290-4325 Fax: 515-280-9525 |
New Life Family Medicine P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1610 W Townline St, Suite 100, Creston, IA 50801 Phone: 641-782-3877 Fax: 641-782-3879 |
Morning Star Internal Medicine Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1610 W Townline St, Suite 110, Creston, IA 50801 Phone: 641-782-3641 Fax: 641-782-3640 |
Creston Medical Clinic, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1610 W Townline St, Suite 200, Creston, IA 50801 Phone: 641-782-2131 Fax: 641-782-6425 |
Internal Medicine Consultants, P.c. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 W Townline St, Suite 1, Creston, IA 50801 Phone: 641-782-6440 Fax: 641-782-6515 |
News Archive
BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.
Taro Pharmaceutical Industries Ltd. today provided preliminary, unaudited and unreviewed information on its financial performance for the first half of 2010.
A leading psychologist has claimed that humans' ability to generate feelings through imagery – as, for instance, becoming sexually aroused through fantasy - could be the key to a breakthrough in the treatment of a range of mental health problems.
A British team has been given the green light to perform the world's first full-face transplant.
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.
› Verified 6 days ago